Bangor Savings Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Bangor Savings Bank’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$534K	Hold	857	–	–	0.04%	156
2026 Q1	$662K	Hold	857	–	–	0.05%	133
2025 Q4	$661K	Hold	857	–	–	0.05%	133
2025 Q3	$482K	Sell	857 -30	-3%	-$17K	0.04%	164
2025 Q2	$466K	Hold	887	–	–	0.04%	160
2025 Q1	$563K	Sell	887 -65	-7%	-$44.7K	0.05%	152
2024 Q4	$678K	Sell	952 -64	-6%	-$53.7K	0.06%	136
2024 Q3	$1.07M	Hold	1,016	–	–	0.1%	104
2024 Q2	$1.07M	Buy	1,016 +16	+2%	+$15.5K	0.11%	106
2024 Q1	$962K	Hold	1,000	–	–	0.1%	115
2023 Q4	$878K	Hold	1,000	–	–	0.1%	117
2023 Q3	$823K	Hold	1,000	–	–	0.1%	120
2023 Q2	$719K	Hold	1,000	–	–	0.08%	133
2023 Q1	$822K	Hold	1,000	–	–	0.1%	120
2022 Q4	$721K	Hold	1,000	–	–	0.09%	127
2022 Q3	$689K	Buy	+1,000	New	+$629K	0.08%	131

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bangor Savings Bank's REGN Position: Q2 2026 in Review

Bangor Savings Bank held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 857 shares worth $534K. The position accounts for 0.04% of the portfolio, ranked #156.

Bangor Savings Bank first reported a position in REGN in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.07M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Bangor Savings Bank held 857 shares of Regeneron Pharmaceuticals worth $534K as of Q2 2026.
Bangor Savings Bank left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up 0.04% of Bangor Savings Bank's portfolio in Q2 2026, its #156 holding.
Bangor Savings Bank first reported a position in Regeneron Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
Bangor Savings Bank's Regeneron Pharmaceuticals position peaked at $1.07M in Q3 2024.
1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Bangor Savings Bank's 13F filing for Q2 2026, filed 6 Jul 2026.